Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-07-01FDA Approved: ATENOLOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Atenolol from Mylan Pharmaceuticals Inc., approving changes to the approved ANDA.
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated the effectiveness of Nigella sativa seed for dyslipidemia; the study, conducted by Aga Khan University,…
-
FDA approval · 2015-06-30FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Supplemental Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s supplemental application for quinapril/hydrochlorothiazide fixed-dose combinations (10/12.5, 20/12.5, 20/2…
-
FDA approval · 2015-06-30FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (Sandoz Inc), a generic benazepril hydrochlorid…
-
FDA label_change · 2015-06-29FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (Natco Pharma USA LLC)
FDA approved a supplemental application for Bisoprolol Fumarate (Natco Pharma USA LLC), resulting in labeling changes for the product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-06-26Clinical Trial Update: The Dutch National Renal Denervation Registry
This document provides an update on the Dutch National Renal Denervation Registry, sponsored by UMC Utrecht, focusing on data collection rel…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Developing an Integrated System Approach for the Management of Hypertension: A Pilot Study [NA]
This document reports the completion of a pilot clinical trial evaluating an integrated system approach for the management of hypertension.
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension [NA]
A pilot study comparing plasma renin activity-guided hypertension therapy to generic combination therapy; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Pumpkin Seed Oil Supplementation in Premenopausal Women [Phase 2]
A Phase 2 trial evaluated pumpkin seed oil supplementation in premenopausal women for blood pressure effects; the study is completed.
-
FDA approval · 2015-06-16FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis Pharmaceuticals …
-
CLINICAL_TRIALS trial_result · 2015-06-12Clinical Trial Update: Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 [Phase 1]
Phase 1 pharmacokinetic interaction study assessing potential interactions among Hanmi's HGP0904, HGP0608, and HGP1405 in hypertension; resu…
-
FDA approval · 2015-06-11FDA Approved: ATENOLOL AND CHLORTHALIDONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the atenolol and chlorthalidone combination product from Actavis Pharma, Inc. This action grants…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome [Phase 4]
A Phase 4 randomized open-label trial compared fixed-dose combinations of amlodipine/valsartan versus telmisartan/hydrochlorothiazide to ass…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Salt Reduction on Blood Pressure and Cardiovascular Organ Damage [Phase 3]
Phase 3 trial update noting the completion of a study evaluating whether salt reduction lowers blood pressure and reduces cardiovascular org…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Extracellular Fluid in Resistant Hypertension [NA]
The clinical trial investigating extracellular fluid in resistant hypertension sponsored by St George's, University of London has been termi…
-
FDA approval · 2015-06-09FDA Approved: VALSARTAN — Original Application (Solco Healthcare US, LLC)
FDA approved the original ANDA for valsartan (generic) submitted by Solco Healthcare US, LLC, authorizing marketing of this ARB for hyperten…
-
FDA label_change · 2015-06-08FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for CARDURA XL (doxazosin mesylate) by Viatris Specialty LLC, typically resulting in labeling change…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: The Effect of Renal Denervation on Renal Flow in Humans [NA]
The update describes a completed clinical trial assessing how renal denervation impacts renal blood flow in humans with hypertension. It lis…
-
FDA approval · 2015-06-05FDA Approved: FUROSEMIDE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
FDA approved a supplemental NDA for furosemide from Marlex Pharmaceuticals, Inc., updating the product label.
-
FDA approval · 2015-06-04FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Cognitive Dysfunction in Hypertensive Patients Having Spine Surgery
The clinical trial investigating cognitive dysfunction in hypertensive patients undergoing spine surgery has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Evaluating the Relationship Between Inflammation, Genetics, and Stress in the Development of High Blood Pressure
A completed clinical trial investigating how inflammation, genetics, and stress may influence the development of hypertension; results were …
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression [Phase 4]
Phase 4 trial evaluating whether CLCNKA gene polymorphisms influence hypertrophy regression in hypertension was withdrawn.
-
FDA approval · 2015-06-03FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' Original Application for a generic three-drug tablet containing amlodipine, valsartan, and hydrochloroth…
-
CLINICAL_TRIALS withdrawal · 2015-06-03Clinical Trial Update: Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study [Phase 4]
Phase 4 trial evaluating safety and blood pressure lowering with a combined angiotensin receptor blocker and calcium antagonist in hypertens…